Cargando…
Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise
Lung cancer is the leading cause of cancer deaths, with an overall survival of 15% at five years. Biomarkers that can sensitively and specifically detect lung cancer at early stage are crucial for improving this poor survival rate. Sputum has been the target for the discovery of non-invasive biomark...
Autores principales: | Kim, Connie E., Tchou-Wong, Kam-Meng, Rom, William N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759181/ https://www.ncbi.nlm.nih.gov/pubmed/24212941 http://dx.doi.org/10.3390/cancers3032975 |
Ejemplares similares
-
NF-kappaB in Lung Tumorigenesis
por: Cai, Zhenjian, et al.
Publicado: (2011) -
Chemoprevention of Lung Cancer: Prospects and Disappointments in Human Clinical Trials
por: Greenberg, Alissa K., et al.
Publicado: (2013) -
Correction: Rapid chemokinetic movement and the invasive potential of lung cancer cells; a functional molecular study
por: Tchou-Wong, Kam-Meng, et al.
Publicado: (2007) -
Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer
por: Su, Jian, et al.
Publicado: (2018) -
Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
por: Njock, Makon-Sébastien, et al.
Publicado: (2019)